Covaxin human trial

Final analysis of Covaxin efficacy out; 65.2 per cent effective against Delta

The efficacy analysis demonstrates Covaxin to be 93.4 per cent effective against severe symptomatic COVID-19 cases

AA Edit | Govt needs to do more to push vaccine awareness

It looks like the government has taken one area for granted -- public awareness about the vaccine

Bharat Biotech’s Covaxin shows ‘encouraging results’ in phase-I of human trials

Covaxin is one of the only two indigenous COVID vaccine candidates approved for human clinical trials in India

1 of 1